跳转至内容
Merck
CN
所有图片(1)

文件

1.10316

Millipore

Fractogel EMD TMAE Hicap (M)

登录查看公司和协议定价
所有图片(1)
别名:
Fractogel® EMD TMAE Hicap (M)
UNSPSC代码:
41115711

ligand

(Trimethylammoniumethyl)

质量水平

400

描述

strong anion exchanger, suspension in 20% ethanol and 150 mM NaCl (40-90 µm)

无菌性

sterile (Caustic Stable)

形式

resin

特殊分析物

MAbs

参数

180 cm/hr flow rate
8 bar max. pressure

基质活性基团

methacrylate

平均粒径

40-90 μm

容量

180 mg binding capacity (BSA/mg of resin)

转变温度

flash point 35 °C (calculated)

密度

1.430 g/cm3 at 20 °C

堆积密度

1000 kg/m3

应用

recombinant protein

分离技术

anion exchange
strong anion exchange

储存温度

2-30°C

正在寻找类似产品? 访问 产品对比指南

相关类别

一般描述

Strong anion exchange Fractogel® resin featuring the tentacle technology with a trimethylammoniumethyl functional group for purification of acidic and neutral proteins and peptides from multiple sources, DNA and virus removal, plasmid purification, vaccine purification, and more

特点和优势

Fractogel® EMD TMAE Hicap (M) enables users to:

  • Efficiently capture target protein and remove viruses, DNA, and endotoxins with its tentacle technology resulting in better production yields and high throughput
  • Reduce operating costs and resin replacement with enduring durability - allowing for multiple cycles of column regeneration and sanitization
  • Compatibility with 2.5 % (v/v) aqueous benzyl alcohol containing 150 mM NaCl storage solution


Due to the titration behavior of Fractogel® EMD TMAE Hicap (M) the ion exchange capacity can be used from pH 2 to 12. The separation of proteins is based on reversible electrostatic interactions between the negatively charged regions of the proteins′ surface and the support. Proteins are retained efficiently on Fractogel® EMD TMAE Hicap (M) when the pH of the buffer is about 1 unit above their isoelectric points (pl).

The strength of the binding depends on the following:
  • the buffer system
  • pH value of the buffer which determines the surface charge of the protein
  • the concentration of the counter ions
  • the charge density on the support (protein binding capacity)

包装

  • 1.10316.0100: Fractogel® EMD TMAE Hicap (M) Resin 100ml
  • 1.10316.0010: Fractogel® EMD TMAE Hicap (M) Resin 10ml
  • 1.10316.0500: Fractogel® EMD TMAE Hicap (M) Resin 500ml
  • 1.10316.5000: Fractogel® EMD TMAE Hicap (M) Resin 5L

Plastic bottle

分析说明

Appearance: Milky turbid suspension, free from impurities (foreign particles)
Microscopic evaluation: Uniform spherical particles,no agglomerates,no fines
Extractable matter (water): ≤ 0.03 %
Cerium: ≤ 1 µg/g
Pressure drop(column: ID=1.6 cm, L=10 cm at 5 ml/min): ≤ 1 bar
Particle size (d10): 37 - 45 µm
Particle size (d50): 48 - 60 µm
Particle size (d90): 63 - 77 µm
Colony forming units (TAMC + TYMC): ≤ 100 CFU/ml
Endotoxins: ≤ 1.00 EU/ml
Protein binding capacity (bovine serum albumin): 160 - 200 mg/ml
Functional test (b:a): ≤ 0.25
Functional test: Separation of conalbumin and human serum albumin

法律信息

FRACTOGEL is a registered trademark of Merck KGaA, Darmstadt, Germany

象形图

Flame
GHS02

警示用语：

Warning

危险声明

H226

危险分类

Flam. Liq. 3

储存分类代码

3 - Flammable liquids

WGK

WGK 1

闪点(°F)

95.0 °F

闪点(°C)

35 °C

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

商品

Egg-based and Cell-based Influenza Vaccine Manufacturing Methods

Influenza vaccines are commonly made using egg-based and cell-based manufacturing strategies. Find step-by-step information on the manufacturing process for each method.

Cost Modeling Vaccine Manufacturing: Estimate Production Costs for mRNA and other Vaccine Modalities

A custom-designed cost model is used to explore the economics of vaccine manufacturing across several different modalities including mRNA. The model enables greater process understanding, simulates bottlenecks, and helps to optimize production efficiency.

Developing and Manufacturing Attenuated Viral Vaccines

Learn more one the attenuated viral vaccines manufacturing process: cell culture, clarification, nuclease treatment, chromatography, and sterile filtration.

Virus-like Particle (VLP) Vaccine Bioprocessing and Formulation Steps

This technical article breaks down the steps of upstream and downstream bioprocessing and formulation of virus-like particle vaccines.

查看所有结果

相关内容

Adenovirus Vaccine Manufacturing Process

This technical article breaks down the adenovirus vaccine manufacturing process and provides a case study on developing an accelerated and cost-effective single-use adenoviral vector vaccine.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门